Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atrial Fibrillation (AF) Ablation to Prevent Disease Progression of AF-induced Atrial Cardiomyopathy in Women and Men

NCT06200311 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT06200311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06200311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atrial Fibrillation (AF) Ablation to Prevent Disease Progression of AF-induced Atrial Cardiomyopathy in Women and Men
Lead sponsor
University Medical Center Groningen
Phase
Not applicable
Overall status
Recruiting
Start date
July 25, 2024
Completion date
July 25, 2029
Enrollment
604 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial cardiomyopathy, fibrillation, atrial